Advertisement

Higher maximum doses of oxytocin are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery

      Objective

      The objective of the study was to more precisely estimate the effect of maximum oxytocin dose on uterine rupture risk in patients attempting vaginal birth after cesarean (VBAC) by considering timing and duration of therapy.

      Study Design

      A nested case-control study was conducted within a multicenter, retrospective cohort study of more than 25,000 women with at least 1 prior cesarean delivery, comparing cases of uterine rupture with controls (no rupture) while attempting VBAC. Time-to-event analyses were performed to examine the effect of maximum oxytocin dose on the risk of uterine rupture considering therapy duration, while adjusting for confounders.

      Results

      Within the nested case-control study of 804 patients, 272 were exposed to oxytocin: 62 cases of uterine rupture and 210 controls. Maximum oxytocin ranges above 20 mU/min increased the risk of uterine rupture 4-fold or greater (21-30 mU/min: hazard ratio [HR] 3.92, 95% confidence interval [CI], 1.06 to 14.52; 31-40 mU/min: HR 4.57, 95% CI, 1.00 to 20.82).

      Conclusion

      These findings support a maximum oxytocin dose of 20 mU/min in VBAC trials to avoid an unacceptably high risk of uterine rupture.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Macones G.A.
        • Peipert J.
        • Nelson D.B.
        • et al.
        Maternal complications with vaginal birth after cesarean delivery: A multicenter study.
        Am J Obstet Gynecol. 2005; 193: 1656-1662
        • Landon M.B.
        • Hauth J.C.
        • Leveno K.J.
        • et al.
        Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery.
        N Engl J Med. 2004; 351: 2581-2589
        • Martin J.A.
        • Hamilton B.E.
        • Sutton P.D.
        • Ventura S.J.
        • Menacker F.
        • Kirmeyer S.
        Births: Final data for 2004.
        Natl Vital Stat Rep. 2006; 55: 1-101
        • Goetzl L.
        • Shipp T.D.
        • Cohen A.
        • Zelop C.M.
        • Repke J.T.
        • Lieberman E.
        Oxytocin dose and the risk of uterine rupture in trial of labor after cesarean.
        Obstet Gynecol. 2001; 97: 381-384
        • Grambsch P.M.
        Goodness-of-fit and diagnostics for proportional hazards regression models.
        Cancer Treat Res. 1995; 75: 95-112
        • Zelop C.M.
        • Shipp T.D.
        • Repke J.T.
        • Cohen A.
        • Caughey A.B.
        • Lieberman E.
        Uterine rupture during induced or augmented labor in gravid women with one prior cesarean delivery.
        Am J Obstet Gynecol. 1999; 181: 882-886
        • Ravasia D.J.
        • Wood S.L.
        • Pollard J.K.
        Uterine rupture during induced trial of labor among women with previous cesarean delivery.
        Am J Obstet Gynecol. 2000; 183: 1176-1179
        • Lin C.
        • Raynor B.D.
        Risk of uterine rupture in labor induction of patients with prior cesarean section: an inner city hospital experience.
        Am J Obstet Gynecol. 2004; 190: 1476-1478
        • Landon M.B.
        • Leindecker S.
        • Spong C.Y.
        • et al.
        The MFMU Cesarean Registry: Factors affecting the success of trial of labor after previous cesarean delivery.
        Am J Obstet Gynecol. 2005; 193: 1016-1023
        • Cahill A.G.
        • Stamilio D.M.
        • Odibo A.O.
        • Peipert J.F.
        • Stevens E.J.
        • Macones G.A.
        Does a maximum dose of oxytocin affect risk for uterine rupture in candidates for vaginal birth after cesarean delivery?.
        Am J Obstet Gynecol. 2007; 197 (e1-5): 495